พื้นที่โฆษณา

/DISREGARD RELEASE: Antengene Corporation Limited/

PR Newswire

พีอาร์ นิวส์ไวร์

ภาษาไทย| English
Like This Page?
PR Newswire - /DISREGARD RELEASE: Antengene Corporation Limited/
PR Newswire Jul 28, 25

Share This Page :

We are advised by Antengene Corporation Limited that journalists and other readers should disregard the news release, Antengene Announces XPOVIO® Approved in China for the Second-Line Treatment of Multiple Myeloma, Marking the Third Approved Indication of the Drug, issued 28-Jul-2025 over PR Newswire.

Source : CISION PR Newswire - /DISREGARD RELEASE: Antengene Corporation Limited/ https://www.prnasia.com/story/archive/4735949_AE35949_0

The information provided in this article was created by CISION PR Newswire, our news partner. The author's opinions and the content shared on this page are their own and may not necessarily represent the perspectives of Thai PR News.

Comment

พื้นที่โฆษณา